VYNE Therapeutics CEO David Domzalski's 2023 pay jumps 110% to $2.7M
VYNE Therapeutics reports 2023 executive compensation
By ExecPay News
Published: November 12, 2024
VYNE Therapeutics reported fiscal year 2023 executive compensation information on November 12, 2024.
In 2023, three executives at VYNE Therapeutics received on average a compensation package of $1.7M, a 92% increase compared to previous year.
Average pay of disclosed executives at VYNE Therapeutics
David Domzalski, Chief Executive Officer, received $2.7M in total, which increased by 110% compared to 2022. 23% of Domzalski's compensation, or $638K, was in salary. Domzalski also received $383K in bonus, $574K in non-equity incentive plan, $502K in option awards, $608K in stock awards, as well as $13K in other compensation.
Iain Stuart, Chief Scientific Officer, received a compensation package of $1.2M, which increased by 78% compared to previous year. 36% of the compensation package, or $422K, was in salary.
Mutya Harsch, Chief Legal Officer, earned $1.1M in 2023, a 72% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on November 12, 2024.